Chemotherapy and radiotherapy use in patients with lung cancer in Australia, Canada, the UK and Norway 2012–2017: an ICBP population-based study
Background International variation in lung cancer survival may be partly explained by variation in stage-specific treatment use, but relevant comparative evidence is sparse. As part of the International Cancer Benchmarking Partnership, we examined use of chemotherapy and radiotherapy in population-b...
Saved in:
Similar Items
-
Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)
by: David Weller, et al.
Published: (2019-11-01) -
The ventilator and the vaccine: Necropolitics and fat in the Covid-19 pandemic
by: Deborah McPhail
Published: (2024-03-01) -
Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data
by: David Weller, et al.
Published: (2022-12-01) -
Conceptual Progression in Innovative Learning Spaces
by: Graham John McPhail
Published: (2015-12-01) -
Strategy for gene expression-based biomarker discovery
by: Joseph Monforte, et al.
Published: (2005-04-01)